Elizabeth Ann  Altman net worth and biography

Elizabeth Altman Biography and Net Worth

Director of Veradigm
Beth Altman has more than 25 years of experience in accounting, finance, management, business development, strategic planning and corporate governance at accounting firm KPMG.  Most recently and until her retirement on September 2019, Ms. Altman served as an Office Managing Partner, where she successfully led a team of more than 260 professionals and 23 partners, providing an array of assurance, tax and advisory services to public and private companies across all industry sectors.  Additionally, Beth served as the lead audit partner for numerous early-stage, middle-market and large global clients in the public and private markets, predominantly in the life sciences, consumer markets and technology sectors.  Since October 2019, Beth has served on the board of directors and on the audit committee of CV Sciences, Inc., which trades on the OTC:QB Marketplace.  Beth also served as a board member of the Corporate Directors Forum, a 501(c)(6) nonprofit organization focused on helping directors, and those who support them, build more effective boards through continuous learning and peer networking.  She also held a leadership position in the San Diego Chapter of Women Corporate Directors, the world’s largest membership organization and community of today’s preeminent women leaders in business.

What is Elizabeth Ann Altman's net worth?

The estimated net worth of Elizabeth Ann Altman is at least $239,293.44 as of June 16th, 2023. Ms. Altman owns 31,158 shares of Veradigm stock worth more than $239,293 as of April 23rd. This net worth approximation does not reflect any other investments that Ms. Altman may own. Learn More about Elizabeth Ann Altman's net worth.

How do I contact Elizabeth Ann Altman?

The corporate mailing address for Ms. Altman and other Veradigm executives is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. Veradigm can also be reached via phone at (800) 334-8534 and via email at [email protected]. Learn More on Elizabeth Ann Altman's contact information.

Has Elizabeth Ann Altman been buying or selling shares of Veradigm?

Elizabeth Ann Altman has not been actively trading shares of Veradigm during the past quarter. Most recently, Elizabeth Ann Altman sold 6,028 shares of the business's stock in a transaction on Friday, May 27th. The shares were sold at an average price of $16.75, for a transaction totalling $100,969.00. Following the completion of the sale, the director now directly owns 22,796 shares of the company's stock, valued at $381,833. Learn More on Elizabeth Ann Altman's trading history.

Who are Veradigm's active insiders?

Veradigm's insider roster includes Elizabeth Altman (Director), Paul Black (CEO), Greg Garrison (Director), Lisa Khorey (Insider), Michael Klayko (Director), and Richard Poulton (CFO). Learn More on Veradigm's active insiders.

Elizabeth Ann Altman Insider Trading History at Veradigm

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/27/2022Sell6,028$16.75$100,969.0022,796View SEC Filing Icon  
6/14/2021Sell11,600$17.78$206,248.0028,824View SEC Filing Icon  
See Full Table

Elizabeth Ann Altman Buying and Selling Activity at Veradigm

This chart shows Elizabeth Ann Altman's buying and selling at Veradigm by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Veradigm Company Overview

Veradigm logo
Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Read More

Today's Range

Now: $7.68
Low: $7.41
High: $7.90

50 Day Range

MA: $7.77
Low: $6.13
High: $8.52

2 Week Range

Now: $7.68
Low: $5.01
High: $14.09

Volume

243,838 shs

Average Volume

821,829 shs

Market Capitalization

$839.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.65